[1]
2025. Preparation and Characterization of a Nanostructured Lipid Carrier-Based Formulation of Pioglitazone for Enhanced Antidiabetic Activity. International Journal of Environmental Sciences. 11, 10s (Jun. 2025), 464–473. DOI:https://doi.org/10.64252/zpg19n51.